Comparing two different intravenous doses of granisetron in prevention of spinal Anesthesia induced shivering in cesarean section.

Phase 2

Recruiting

• Conditions: Cesarean delivery.; Newborn (suspected to be) affected by Cesarean delivery; P03.4

• Registration Number: IRCT20141009019470N81
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 260

Inclusion Criteria

ASA I-II
Aged 18 to 40
Elective cesarean section

Exclusion Criteria

Addicted to drug
History of neuromuscular diseases
Cardiac failure grade 3 and 4
Contraindication of the spinal anesthesia
History of hypertension or cardiovascular disease
Temperature is less than 36.5 ° C or above 38 ° before surgery
Hypothyroidism or Hyperthyroidism
The need for blood transfusion during surgery and medications that cause changes in body temperature or nausea and vomiting.
The history of shivering from the operation
Failure of the spinal anesthesia leading to general anesthesia
History of sensitivity to Granisetron or ondonestrone.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Shivering. Timepoint: Peri-operatively and in the recovery room every 10 min. Method of measurement: Tsai and Chu Table.;Nausea and Vomiting. Timepoint: Peri-operatively and in the recovery room every 10 min and in the ward every 2,4,6 and 12 hour postoperatively. Method of measurement: Visual analog score.

Secondary Outcome Measures

Name	Time	Method
Apgar score. Timepoint: At 1,5 min after birth. Method of measurement: Apgar score.